Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Cash management reports

Cash management reports

Synergen Inc. (SYGN) and Centocor Inc. (CNTO) reported positive progress in their crash programs to slash spending.

CNTO surpassed its $15 million cash-burn rate goal for the second quarter ended June 30, burning $12.2

Read the full 366 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE